NASDAQ:MGNX
MacroGenics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.macrogenics.comipo date
Oct 10, 2013
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive bre...Show More
Earnings
Earnings Release in 11 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus